Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Uncovering TK2d: How to Navigate Diagnostic Challenges
Navigating Emerging Biomarkers in MS Care
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The New Era of Targeted Therapy for Myasthenia Gravis
A Closer Look at the Biology Behind MS Progression
New Therapies, New Strategy: Rethinking MG Inpatient Care
More Than a Myopathy: The Lived Experience of TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.